These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 2193064)

  • 1. Effect of brodimoprim on Mycobacterium leprae in vitro and in mouse foot-pads.
    Dhople AM; Ortega I; Seydel JK; Gardner GD
    Indian J Lepr; 1990; 62(1):76-86. PubMed ID: 2193064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo experiments with the new inhibitor of mycobacterium leprae brodimoprim alone and in combination with dapsone.
    Seydel JK; Wempe EG; Rosenfeld M; Jagannathan R; Mahadevan PR; Dhople AM
    Arzneimittelforschung; 1990 Jan; 40(1):69-75. PubMed ID: 2187440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo activity of K-130, a dihydrofolate reductase inhibitor, against Mycobacterium leprae.
    Dhople AM
    Arzneimittelforschung; 1999 Mar; 49(3):267-71. PubMed ID: 10219472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo activity of epiroprim, a dihydrofolate reductase inhibitor, singly and in combination with dapsone, against Mycobacterium leprae.
    Dhople AM
    Int J Antimicrob Agents; 2002 Jan; 19(1):71-4. PubMed ID: 11814771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of epiroprim, a dihydrofolate reductase inhibitor, singly and in combination with brodimoprim and dapsone, against Mycobacterium leprae.
    Dhople AM
    Int J Antimicrob Agents; 1999 Aug; 12(4):319-23. PubMed ID: 10493608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo effects of N-methyl-3,5-dichloro-benzylamine hydrochloride on Mycobacterium leprae.
    Dhople AM; Strong LC; Meindl W; Schoenenberger H; Gardner GD
    Arzneimittelforschung; 1991 Mar; 41(3):253-6. PubMed ID: 1867663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse foot-pad studies with M. leprae--effect of desoxy fructo serotonin (DFS) and related compounds.
    Balakrishnan S; Mester L; Venkataramaniah HN; Bhatia VN
    Indian J Lepr; 1985; 57(2):323-8. PubMed ID: 3908578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo susceptibility of Mycobacterium leprae to ofloxacin either singly or in combination with rifampicin and rifabutin. Anti-leprosy activity of ofloxacin and ansamycins in mice.
    Dhople AM; Ibanez MA
    Arzneimittelforschung; 1994 Apr; 44(4):563-5. PubMed ID: 8011013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mouse foot-pad technique for cultivation of Mycobacterium leprae.
    Levy L; Ji B
    Lepr Rev; 2006 Mar; 77(1):5-24. PubMed ID: 16715686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of desoxy fructo serotonin (DFS) on the multiplication of M. leprae in mouse foot-pad.
    Balakrishnan S; Mester L; Venkataramanaiah HN; Bhatia VN
    Lepr India; 1982 Jan; 54(1):56-8. PubMed ID: 7047899
    [No Abstract]   [Full Text] [Related]  

  • 11. Activity of ascorbic acid in inhibiting the multiplication of M. leprae in the mouse foot pad.
    Hastings RC; Richard V; Christy SA; Morales MJ
    Int J Lepr Other Mycobact Dis; 1976; 44(4):427-30. PubMed ID: 798727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse foot pad technique for evaluation of drug resistance of M. leprae and other laboratory techniques to be used in leprosy control programmes.
    Pattyn SR
    Acta Leprol; 1983; 1(1):29-32. PubMed ID: 6401137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial growth kinetics of "M. lufu" in the presence and absence of various drugs alone and in combination. A model for the development of combined chemotherapy against M. leprae?
    Seydel JK; Wempe EG
    Int J Lepr Other Mycobact Dis; 1982 Mar; 50(1):20-30. PubMed ID: 7042611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Search for newer antileprosy drugs.
    Dhople AM
    Indian J Lepr; 2000; 72(1):5-20. PubMed ID: 10935183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vitro activities of rifamycin analogues against Mycobacterium leprae.
    Dhople AM
    Indian J Lepr; 1997; 69(4):377-84. PubMed ID: 9474513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of dihydrofolate reductase inhibitors on Mycobacterium Leprae in the mouse foot pad.
    Gelber RH; Levy L
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):124-32. PubMed ID: 776847
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug susceptibility of Mycobacterium leprae: a retrospective analysis of mouse footpad inoculation results from 1983 to 1997.
    Sekar B; Elangeswaran N; Jayarama E; Rajendran M; Kumar SS; Vijayaraghavan R; Anandan D; Arunagiri K
    Lepr Rev; 2002 Sep; 73(3):239-44. PubMed ID: 12449888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of rifampicin resistance and comparison of dapsone resistance of M. leprae in pre- and post-MDT era.
    Gupta UD; Katoch K; Katoch VM
    Indian J Lepr; 2009; 81(3):131-4. PubMed ID: 20509341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin.
    Matsuoka M; Kashiwabara Y; Namisato M
    Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):452-5. PubMed ID: 11332288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo interactions of drugs used in multidrug therapy in leprosy.
    Dhople AM; Lamoureux LC; Gardner GD
    Indian J Lepr; 1991; 63(2):166-79. PubMed ID: 1664440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.